US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

98.97

+0.83000.85%

Post-market: 99.500.5300+0.54%17:03 EDT

Volume:576.01K

Turnover:57.52M

Market Cap:4.13B

PE:-15.36

High:102.29

Open:99.45

Low:98.82

Close:98.14

52wk High:131.24

52wk Low:32.00

Shares:41.78M

Float Shares:32.29M

Volume Ratio:1.21

T/O Rate:1.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:5.08

PE(LYR):-0.88

Loading ...

Overview Company News Filings

Veradermics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $170

THOMSON REUTERS

Veradermics to Discuss Phase 2 Results for Oral Minoxidil Hair-loss Drug Vdphl01 on July 15 Webcast

Veradermics is Maintained at Buy by Jefferies

Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL) and Veradermics, Incorporated (MANE)

Veradermics price target raised to $182 from $138 at Jefferies

Analysts’ Top NA Picks: Newron Pharmaceuticals SpA (NWPHF), Veradermics, Incorporated (MANE)

Veradermics Initiated at Outperform by LifeSci Capital

Veradermics, Incorporated (MANE) Receives a Buy from Jefferies

Analysts Offer Insights on NA Companies: Veradermics, Incorporated (MANE) and Fiserv (FISV)

As SpaceX IPO anticipation heats up, what 2026's biggest IPOs say about investor demand

Veradermics posts corporate deck highlighting VDPHL01 oral minoxidil program for pattern hair loss

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, Md to Board of Directors

THOMSON REUTERS

Veradermics Initiated at Buy by Needham

Veradermics initiated with a Buy at Needham

Needham Initiates VeraDermics at Buy With $136 Price Target

MT Newswires Live

Veradermics Inc : Needham Initiates Coverage With Buy Rating; Price Target $136

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Veradermics to Present at Jefferies Global Healthcare Conference

Veradermics to present Phase 2/3 topline data for VDPHL01 oral minoxidil in male pattern hair loss at May 2026 congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/MANE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":98.97,"timestamp":1789156800000,"preClose":98.14,"halted":0,"volume":576005,"hourTrading":{"tag":"盘后","latestPrice":99.5,"preClose":98.97,"latestTime":"17:03 EDT","volume":3215,"amount":318239.2184,"timestamp":1789160584795,"change":0.53,"changeRate":0.005355,"amplitude":0.015762},"delay":0,"changeRate":0.00845730588954553,"floatShares":32290700,"shares":41778687,"eps":-6.443948,"marketStatus":"Post-Mkt","change":0.83,"latestTime":"09-11 17:40:05 EDT","open":99.45,"high":102.29,"low":98.815,"amount":57518632.40935,"amplitude":0.035409,"askPrice":100.9,"askSize":19,"bidPrice":98.42,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":98.14,"preHourTrading":{"tag":"盘前","latestPrice":101.97,"preClose":98.14,"latestTime":"09:27 EDT","volume":23,"amount":2263.98039,"timestamp":1789133271809,"change":3.83,"changeRate":0.039026,"amplitude":0.036275},"postHourTrading":{"tag":"盘后","latestPrice":99.5,"preClose":98.97,"latestTime":"17:03 EDT","volume":3215,"amount":318239.2184,"timestamp":1789160584795,"change":0.53,"changeRate":0.005355,"amplitude":0.015762},"volumeRatio":1.208998,"impliedVol":1.1183,"impliedVolPercentile":0.881},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":32290700,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":1.208998,"shares":41778687,"dividePrice":0,"high":102.29,"amplitude":0.035409,"preClose":98.14,"low":98.815,"week52Low":32,"pbRate":"5.08","week52High":131.2399,"institutionHeld":0,"latestPrice":98.97,"committee":-0.9,"eps":-6.443948,"divideRate":0,"volume":576005,"delay":0,"ttmEps":-6.443948,"open":99.45,"prevYearClose":17,"prevWeekClose":98.51,"prevMonthClose":98.41,"prevQuarterClose":122.94,"fiveDayClose":97.75,"twentyDayClose":111,"sixtyDayClose":90.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-09-10","current":-15.358597,"percent":0.573333,"low":-67.545361,"twenty":-54.102924,"median":-46.493546,"eighty":-34.242062,"high":-9.296992,"avg":-45.280509,"sd":10.750116,"marketCap":4164226155},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923},{"date":"2026-08-28","current":-45.893958,"twenty":-54.263485,"median":-47.316049,"eighty":-33.861631,"marketCap":4253635646},{"date":"2026-09-04","current":-44.06379,"twenty":-54.197488,"median":-46.684099,"eighty":-34.12449,"marketCap":4084008294},{"date":"2026-09-10","current":-44.929288,"twenty":-54.102924,"median":-46.493546,"eighty":-34.242062,"marketCap":4164226155}],"updateTime":1789162805427},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651743572","title":"Veradermics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $170","url":"https://stock-news.laohu8.com/highlight/detail?id=2651743572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651743572?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:23","pubTimestamp":1784085815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43G14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482521","title":"Veradermics to Discuss Phase 2 Results for Oral Minoxidil Hair-loss Drug Vdphl01 on July 15 Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482521","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482521?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:54","pubTimestamp":1784069661,"startTime":"0","endTime":"0","summary":"Veradermics to discuss Phase 2 results for oral minoxidil hair-loss drug VDPHL01 on July 15 webcastVeradermics scheduled an investor call and webcast for July 15, 2026 at 8:00 a.m. ET to review Phase ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL6QCSHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649082939","title":"Veradermics is Maintained at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649082939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649082939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:27","pubTimestamp":1783441620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings(END) Dow Jones NewswiresJuly 07, 2026 12:27 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649382569","title":"Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL) and Veradermics, Incorporated (MANE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649382569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649382569?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:20","pubTimestamp":1783430417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Guardian Metal Resources PLC Sponsored ADR (GMTL) and Veradermics, Incorp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-na-names-guardian-metal-resources-plc-sponsored-adr-gmtl-and-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-na-names-guardian-metal-resources-plc-sponsored-adr-gmtl-and-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","APIE","BK4141","BK4007","CVY","DIVL","GMTL","NA","DINT","BK4168","AADR","SAPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649389549","title":"Veradermics price target raised to $182 from $138 at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649389549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649389549?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:00","pubTimestamp":1783429236,"startTime":"0","endTime":"0","summary":"Jefferies raised the firm’s price target on Veradermics (MANE) to $182 from $138 and keeps a Buy rating on the shares. The firm expects VDPHL01 Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-182-from-138-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-182-from-138-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645802912","title":"Analysts’ Top NA Picks: Newron Pharmaceuticals SpA (NWPHF), Veradermics, Incorporated (MANE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645802912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645802912?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:44","pubTimestamp":1782125073,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Newron Pharmaceuticals SpA (NWPHF) and Veradermics, Incorpor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-newron-pharmaceuticals-spa-nwphf-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-newron-pharmaceuticals-spa-nwphf-veradermics-incorporated-mane-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","BK4007","NA","NWPHF","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644761861","title":"Veradermics Initiated at Outperform by LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2644761861","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644761861?lang=en_us&edition=fundamental","pubTime":"2026-06-17 01:01","pubTimestamp":1781629260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 13:01 ET (17:01 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643757726","title":"Veradermics, Incorporated (MANE) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2643757726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643757726?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:00","pubTimestamp":1781614815,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Veradermics, Incorporated today and set a price target of $138.00. Song covers the Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/veradermics-incorporated-mane-receives-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/veradermics-incorporated-mane-receives-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643575269","title":"Analysts Offer Insights on NA Companies: Veradermics, Incorporated (MANE) and Fiserv (FISV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643575269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643575269?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:11","pubTimestamp":1781611901,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Veradermics, Incorporated (MANE) and Fiserv (FISV). Verade...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-veradermics-incorporated-mane-and-fiserv-fisv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-veradermics-incorporated-mane-and-fiserv-fisv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1923622291.USD","BK4227","LU0980610538.SGD","LU0354030511.USD","BK4585","LU2125909759.SGD","FISV","LU1861220207.SGD","LU0354030438.USD","LU0208291251.USD","LU1823568750.SGD","LU1861217088.USD","BK4588","LU0070302665.USD","LU2125909916.SGD","LU0648001328.SGD","MANE","LU0648000940.SGD","NA","BK4106","LU1046421795.USD","LU1201861165.SGD","BK4007","LU0130103400.USD","LU1201861249.SGD","LU0130102774.USD","BK4141","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642149405","title":"As SpaceX IPO anticipation heats up, what 2026's biggest IPOs say about investor demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2642149405","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642149405?lang=en_us&edition=fundamental","pubTime":"2026-06-10 03:29","pubTimestamp":1781033340,"startTime":"0","endTime":"0","summary":"DataTrek digs into the performance of this year's largest 15 IPOs - and how the pace of listings compares with 1999 during the dot-com bubble. OpenAI has recently filed for an IPO, adding to investor anticipation for blockbuster listings.ChatGPT maker OpenAI on Monday said it had filed confidentially for an initial public offering, following AI rival Anthropic's IPO filing on June 1. Meanwhile, investors are bracing for the biggest IPO ever, with the highly anticipated market debut of SpaceX  expected Friday.The IPO calendar is heating up with blockbuster deals as the bull market for U.S. stocks has run more than three years. DataTrek Research dug into how this year's 15 largest U.S. IPOs have fared, saying in a Tuesday note shared with MarketWatch that the IPO market serves as a gauge of investor confidence.IPO issuance remains \"relatively measured,\" with 68 deals completed this year, after just 90 seen in U.S. equity markets last year, according to the DataTrek note. That compares wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IPOS","CBRS","BK4615","BK4141","DXYZ","MANE","SPCX","UFO","XOVR","BK4089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642365654","title":"Veradermics posts corporate deck highlighting VDPHL01 oral minoxidil program for pattern hair loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2642365654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642365654?lang=en_us&edition=fundamental","pubTime":"2026-06-09 02:06","pubTimestamp":1780941971,"startTime":"0","endTime":"0","summary":"Veradermics outlined late-stage plans for VDPHL01, an extended-release oral minoxidil tablet for pattern hair loss.Study 302 topline data showed statistically significant non-vellus target area hair count gains at month 6: 30.3 hairs  or 33.0  vs 7.3 placebo.Study 304, a phase 3 trial in 552 men, is fully enrolled, with a 6-month topline readout expected in H2 2026.Study 306, a phase 2/3 program in women, is actively enrolling, targeting an oral option in a market the deck sizes at about 80 million US patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL7phpS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948704","title":"Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948704","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948704?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:33","pubTimestamp":1780403603,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences appointed Jeffrey Farrow and Reid Waldman to its board as it prepares a cytisinicline NDA resubmission.Farrow is CFO and chief strategy officer at Tarsus Pharmaceuticals, supporting the commercial launch of XDEMVY for Demodex blepharitis.Waldman is founder and CEO of Veradermics, a clinical-stage biopharmaceutical company developing therapeutics for pattern hair loss.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL7pWhSJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2T93.GBP","BK4139","BK4007","LU0314104364.USD","IE00BKPKM429.USD","MANE","IE00BGHQF748.EUR","NDAQ","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","SG9999014039.USD","SG9999014013.SGD","ACHV","IE00B3QW5Z07.USD","TARS","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640487569","title":"Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, Md to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640487569","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640487569?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:30","pubTimestamp":1780403401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUAP0DCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACHV","MANE","BK4007","TARS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640403914","title":"Veradermics Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2640403914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640403914?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:25","pubTimestamp":1780395900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2026 06:25 ET (10:25 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640291411","title":"Veradermics initiated with a Buy at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2640291411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640291411?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:00","pubTimestamp":1780394410,"startTime":"0","endTime":"0","summary":"Needham initiated coverage of Veradermics (MANE) with a Buy rating and $136 price target The company’s VDPHL01, a late-stage ER minoxidil product c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911998","title":"Needham Initiates VeraDermics at Buy With $136 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640911998?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:51","pubTimestamp":1780393864,"startTime":"0","endTime":"0","summary":"Needham Initiates VeraDermics at Buy With $136 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640919148","title":"Veradermics Inc : Needham Initiates Coverage With Buy Rating; Price Target $136","url":"https://stock-news.laohu8.com/highlight/detail?id=2640919148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640919148?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:34","pubTimestamp":1780392861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0E7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640913560","title":"U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik","url":"https://stock-news.laohu8.com/highlight/detail?id=2640913560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640913560?lang=en_us&edition=fundamental","pubTime":"2026-06-02 15:49","pubTimestamp":1780386551,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik June 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Edgewise","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4N42A0K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAC","EWTX","TMHC","ARXS","CPB","SAIL","TTWO","ACRE","BRKR","SOC","XFOR","ALGT","GOU","SAIC","BWA","CIEN","ORCX","BTSG","ORCU","GOOGL","GOOW","RVMD","FULC","GGLL","IBM","MOBI","ORCL","LTH","U","CAG","HPE","BXMT","EW","ORCS","PRAX","ODTX","MLM","GOOX","VMC","CZR","MANE","GOOY","GH","RBRK","NAVN","GOOP","CHWY","OCTV","UNX","GGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639160196","title":"Veradermics to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2639160196","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639160196?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:30","pubTimestamp":1780000254,"startTime":"0","endTime":"0","summary":"Veradermics will present at the Jefferies Global Healthcare Conference on June 3 in New York.Management will also present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8 in Miami.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL3RwTHv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1668664300.SGD","LU0048573561.USD","LU2750360997.AUD","LU2471134523.USD","LU0345770993.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE0034235188.USD","BK4550","IE0004086264.USD","BK4516","LU0106831901.USD","IE0004091025.USD","LU2750360641.GBP","LU2237443978.SGD","LU1868837136.USD","BK4504","LU1868836914.USD","LU2237443895.HKD","LU2471134879.HKD","IE00BFXG1179.USD","LU2237443549.SGD","BK4127","LU1791807156.HKD","LU1868837300.USD","LU1894683264.USD","LU2237438978.USD","LU1868836757.USD","MANE","IE00BSNM7G36.USD","BK4552","LU2237443382.USD","LU0251131958.USD","LU2237443622.USD","BK4007","LU0251142724.SGD","LU0942090050.USD","LU1804176565.USD","LU2237443465.HKD","BK4588","BK4533","GSX","LU1894683348.USD","LU1868836591.USD","LU2265009873.SGD","LU0096364046.USD","LU2471134796.USD","LU0345770308.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638650267","title":"Veradermics to present Phase 2/3 topline data for VDPHL01 oral minoxidil in male pattern hair loss at May 2026 congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2638650267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638650267?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:30","pubTimestamp":1779881421,"startTime":"0","endTime":"0","summary":"Veradermics set a May 30, 2026 poster at the World Congress for Hair Research to disclose topline Phase 2/3 Study 302 results for VDPHL01.Results were previously shared in April 2026, with the upcoming presentation positioned as a fuller public readout.Part A showed positive outcomes for VDPHL01, an extended-release oral minoxidil tablet, in more than 500 men with mild-to-moderate pattern hair loss.The readout supports plans to advance VDPHL01 as a potential FDA-approved oral pill for pattern hair loss, a category without a new pill in decades.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via Business Wire  on May 27, 2026, and is solely responsible for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL6GGBfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":119,"code":"91000000","status":"200"}]}}